On Sunday, President Trump posted to Truth Social that he planned on implementing a most-favored-nation policy for ...

The Avmapki Fakzynja Co-Pack marks the first FDA-approved treatment for adult patients with KRAS-mutated recurrent low-grade ...

While expressing a desire for revenue growth is common, understanding the “why” behind that intention is crucial. Delving ...

Beyond technology, regulations weigh heavily on the minds of pharma executives. Four out of 10 leaders believe regulatory ...

Lilly announced several changes to its executive leadership team. 1 These changes are mostly related to the company’s ...

Interim results from the ongoing Phase III ASSURE trial demonstrated that Livdelzi maintained a consistent biochemical ...

The use of RWD data in place of placebo groups is improving various elements across the clinical trial space.

Commissioner Markary announced the plans alongside the results of a generative AI pilot for scientific reviewers.

In an effort to combat the state’s shortage of primary care physicians, Blue Cross Blue Shield of Massachusetts is offering ...

Kapil Raina, MD, Principal of Market Access at Herspiegel Consulting, talks about disconnects in the industry, how patients ...

Chip Parkinson, CEO, GiftHealth, explains how AI-powered data integration is bringing new hope to patients by revealing ...

The growing complexity of supply chains necessitates the adoption of collaborative planning processes and capabilities such ...